RxDoctor Payments Data

Amanda Shipp, MD

Family Medicine · Versailles, MONPI 1508152992

Payments from drug & device makers

$886in general payments, 2019–2025

Across 56 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$197
  • AstraZeneca$168
  • Amgen$104
  • Pfizer$76
  • Mylan Specialty L.p.$48
  • Lilly USA, LLC$40
  • plus $251 from 12 others

What the payments were for

  • Food & beverage$886100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$886 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$80,553
Medicare patients
262
Services billed
1,302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide56$102,211
MounjaroTirzepatide87$100,026
EliquisApixaban63$58,922
Synjardy XrEmpagliflozin/Metformin Hcl62$49,784
XareltoRivaroxaban31$48,879
JardianceEmpagliflozin26$46,179
Breztri AerosphereBudesonide/Glycopyr/Formoterol50$44,939
MyrbetriqMirabegron33$30,711
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$28,340
NuedextaDextromethorphan Hbr/Quinidine14$21,476
SymbicortBudesonide/Formoterol Fumarate39$17,147
Xigduo XrDapaglifloz Propaned/Metformin27$16,939
Spiriva RespimatTiotropium Bromide21$15,922
TrulicityDulaglutide16$15,504
Incruse ElliptaUmeclidinium Bromide32$15,156

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$40$115,530103 claims
Boehringer IngelheimSynjardy Xr, Jardiance, Spiriva Respimat$26$111,885109 claims
Novo NordiskOzempic$18$102,21156 claims
GSKTrelegy Ellipta, Incruse Ellipta, Arexvy, Breo Ellipta$17$67,498118 claims
AstraZenecaBreztri Aerosphere, Symbicort$168$62,08589 claims
PfizerEliquis$76$58,92263 claims
Johnson & JohnsonXarelto$24$48,87931 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Versailles

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →